How many institutional investors hold EVMN?

2 tracked institutional investors disclosed a position in EVMN (EVOMMUNE INC) in their most recent 13F filing.

Who is the largest institutional holder of EVMN?

Steve Cohen, Point72 Asset Management, holds the largest disclosed position in EVMN, valued at $19M.

Where does this EVMN ownership data come from?

SEC Form 13F-HR filings, accessed via EDGAR. 13F filings are disclosed quarterly with a 45-day reporting delay and cover U.S.-listed long equity positions only. This is not investment advice.

EVMN — EVOMMUNE INC

Name: EVOMMUNE INC (EVMN) — Institutional Ownership
Creator: InvestorLens
License: https://www.sec.gov/about/website-policies

Public company

For educational research only.InvestorLens analyzes public regulatory filings (SEC EDGAR, STOCK Act PTRs) that may be delayed by 45 days or more. Information shown is historical and is not financial, legal, or tax advice, nor a recommendation or solicitation to buy or sell any security. Always do your own research.

InvestorLens aggregates public filing data to show which tracked investors reported holdings in this stock. Dollar values represent reported position values, not market capitalization, and may be delayed up to 45 days. Not a recommendation.

Sourced from SEC EDGAR public filings

Why are billionaires buying EVMN?

Built from public SEC filings and public economic data. Not a recommendation.

Confidence

Institutional Conviction

Net accumulation · 1 buying vs 0 selling last quarter

Macro Tailwind

Macro conditions are mixed for this sector

Why? — Evidence & Confidence ▾

Of 1 tracked investors who changed their EVMN position last quarter, 1 bought and 0 sold (100% buy-side). Macro conditions are mixed for this sector (Macro Tailwind 55/100 in a Contraction regime).

Supporting evidence

+1 tracked investor added or increased positions last quarter (Steve Cohen)
+2 tracked investors reported holding EVMN at their latest filing
+Macro Health is 55/100 in a Contraction regime — historically acceptable for this sectorsource

Contradicting evidence — always shown

−13F data is disclosed up to 45 days after quarter end — positions may have changed since

Know the limits

· 13F disclosure lag (up to 45 days)
· Tracked investors are a sample, not the whole market
· Sector regime fit is a historical average, not a guarantee

Every InvestorLens score shows its evidence — including what argues against it. Model conviction-v1 · generated 9/17/2026.

About EVOMMUNE INC (EVMN)

EVOMMUNE INC (EVMN) appears in the most recent 13F filings of 2 tracked institutional investors. The largest disclosed position is held by Steve Cohen (Point72 Asset Management), valued at $19M. Across recent filings, tracked investors recorded 1 new positions, 2 increased, 0 reduced, and 1 exited. All data sourced from SEC 13F filings.

Smart Money Consensus™

Based on recent institutional activity in EVMN

/100

Institutional Accumulation

Added / Increased3

Reduced0

Exited1

BearishBullish

Crowded Trade Score™

How many top investors track EVMN

/100

Undiscovered

2investors

Only 2 tracked investors report this position.

UndiscoveredCrowded

151015+

EVMN Ownership Composition

How EVOMMUNE INC is held across tracked investor types, based on reported 13F positions.

Dominant Type

Multi-Strategy / Quant

100% of tracked value

Institutions

tracked investors

Total Reported

$19.7M

combined 13F value

Multi-Strategy / Quant100.0%

Multi-Strategy / Quant(2)

100.0%

Tracked investors currently reporting EVMN

1 tracked investor has since exited this position — listed separately below.

Investor	Firm	Shares	Market value	% of portfolio	As of
Steve Cohen	Point72 Asset Management	1.4M	$19.1M	0.02%	Jun 30, 2026
Ken Griffin	Citadel Advisors	47.9K	$636.9K	0.00%	Jun 30, 2026

Steve CohenJun 30, 2026
Point72 Asset Management
Shares
1.4M
Value
$19.1M
% Portfolio
0.02%
Ken GriffinJun 30, 2026
Citadel Advisors
Shares
47.9K
Value
$636.9K
% Portfolio
0.00%

Previously held EVMN

These investors reported EVMN in an earlier quarter but not in their most recent 13F. Figures below are their last reported position, not a current holding.

Investor	Firm	Last reported shares	Value then	Last held
Paul Tudor Jones	Tudor Investment Corp	32K	$547K	Dec 31, 2025

Recent activity

Investor	Action	Δ %	Current value	Filing date
Steve Cohen	New	—	$588.7K	Feb 17, 2026
Steve Cohen	Increased	6.38%	$840.9K	May 15, 2026
Steve Cohen	Increased	3823.36%	$19.1M	Aug 14, 2026
Paul Tudor Jones	Sold	-100.00%	$0	May 15, 2026

Steve Cohen
New
$588.7KFeb 17, 2026
Steve Cohen
Increased
$840.9K(6.38%)May 15, 2026
Steve Cohen
Increased
$19.1M(3823.36%)Aug 14, 2026
Paul Tudor Jones
Sold
$0(-100.00%)May 15, 2026

Frequently asked questions

How many institutional investors hold EVMN?: 2 tracked institutional investors disclosed a position in EVMN (EVOMMUNE INC) in their most recent 13F filing.
Who is the largest institutional holder of EVMN?: Steve Cohen, Point72 Asset Management, holds the largest disclosed position in EVMN, valued at $19M.
Did institutional ownership of EVMN increase or decrease?: Across recent 13F filings, tracked investors recorded 1 new positions, 2 increased, 0 reduced, and 1 fully exited EVMN.
Where does this EVMN ownership data come from?: SEC Form 13F-HR filings, accessed via EDGAR. 13F filings are disclosed quarterly with a 45-day reporting delay and cover U.S.-listed long equity positions only. This is not investment advice.